Robert Werner Biography and Net Worth

CAO of Invitae

Robert F. Werner serves as Chief Accounting Officer of the Company. He has served as the Company’s Corporate Controller from September 2017 through the effectiveness of his appointment as Chief Accounting Officer and Principal Accounting Officer. Prior to joining the Company, from February 2015 to September 2017, Mr. Werner served as Vice President of Finance and Corporate Controller of Proteus Digital Health, Inc., a digital medicine pharmaceuticals company. Prior to that, Mr. Werner served as Corporate Controller and Principal Accounting Officer of CardioDx, Inc., a molecular diagnostics company, from March 2012 to February 2015. Mr. Werner is a Certified Public Accountant and started his career at Ernst & Young LLP. Mr. Werner holds a Bachelor of Science in Accounting and a Master of Accountancy in Professional Accounting from Brigham Young University’s Marriott School of Management.

What is Robert F. Werner's net worth?: The estimated net worth of Robert F. Werner is at least $43.68 as of March 6th, 2024. Mr. Werner owns 43,680 shares of Invitae stock worth more than $44 as of April 25th. This net worth approximation does not reflect any other investments that Mr. Werner may own. Learn More about Robert F. Werner's net worth.
How do I contact Robert F. Werner?: The corporate mailing address for Mr. Werner and other Invitae executives is 1400 16th Street, SAN FRANCISCO CA, 94103. Invitae can also be reached via phone at (628) 213-3369 and via email at [email protected]. Learn More on Robert F. Werner's contact information.
Has Robert F. Werner been buying or selling shares of Invitae?: Robert F. Werner has not been actively trading shares of Invitae within the last three months. Learn More on Robert F. Werner's trading history.
Who are Invitae's active insiders?: Invitae's insider roster includes Thomas Brida (General Counsel), Sean George (CEO), Shelly Guyer (CFO), Robert Nussbaum (Insider), Katherine Stueland (Insider), and Robert Werner (CAO). Learn More on Invitae's active insiders.
Are insiders buying or selling shares of Invitae?: During the last year, insiders at the medical research company sold shares 5 times. They sold a total of 144,005 shares worth more than $208,408.56. The most recent insider tranaction occured on June, 13th when insider Robert L Nussbaum sold 7,086 shares worth more than $9,778.68. Insiders at Invitae own 0.7% of the company. Learn More about insider trades at Invitae.
Information on this page was last updated on 6/13/2023.

Robert F. Werner Insider Trading History at Invitae

Robert F. Werner Buying and Selling Activity at Invitae

Invitae Company Overview

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Today's Range

Now: $0.00

$0.00

50 Day Range

MA: $0.01

$0.00

$0.02

2 Week Range

Now: $0.00

$0.02

Volume

178,541 shs

Average Volume

23,716,614 shs

Market Capitalization

$267,010.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.59

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...